. Author manuscript; available in PMC: 2023 Dec 11.

Published in final edited form as: ACS Infect Dis. 2022 Nov 3;8(12):2505–2514. doi: 10.1021/acsinfecdis.2c00319

Table 1.

Number of Template Consensus Sequences (TCS) and drug resistance mutations (DRMs) for HIV-1 identified in 4 CHAVI participants who had untreated infections for 36 to 48 weeks.

ID	TCS and detection sensitivity				DRMs, percentage and 95% CI
ID	PR	RT	IN	V1V3	PR	RT	IN
A	1424 (0.3%)	1239 (0.3%)	860 (0.4%)	172 (2.1%)	M46I:0.56(0.24–1.1); L90M:99.86(99.49–99.98);		S147G:0.35(0.07–1.02);
B	909 (0.4%)	730 (0.5%)	1198 (0.3%)	616 (0.6%)			L74M:99.83(99.4–99.98);
C	251 (1.5%)	783 (0.5%)	1070 (0.3%)	237 (1.5%)
D	2985 (0.1%)	2057 (0.2%)	5111 (0.1%)	3020 (0.1%)	D30N:0.23(0.09–0.48); M46I:0.7(0.44–1.07);		V151I:0.14(0.06–0.28);